Once considered obscure or opportunistic, invasive fungal infections are now surfacing with alarming frequency - and in ...

The World Health Organization (WHO) this week published two reports spotlighting gaps in adequate medicines and diagnostic ...

Mandimycin, which targets a different essential fungi cell resource than other antifungal drugs, should harm other cell types as collateral — but doesn’t.

Only four new antifungal drugs were approved over the last decade ... priority’ category of their fungal priority pathogens list (FPPL) are ‘deadly’ and have mortality rates reaching ...